However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period
The placebo and lifestyle change group lost only 5.7 lbs
Epidemiological evidence suggests that sulfonylurea use is associated with an approximately 20% increased risk of specific malignancies, although the causality of this association requires further validation due to current evidence limitations [10]
Novo Nordisk reined in its growth forecasts for the year in its second-quarter financial results update, blaming "persistent use of compounded GLP-1s, slower-than-expected market expansion, and competition." Compounding of semaglutide should have come to a halt in the US since the drug was removed from the FDA list of medicines in short supply, but various companies continue to provide compounded GLP-1s under a loophole that allows the sale of 'personalised' formulations
Not since the emergence and development of liposuction has body shaping been at a turning point like it is now
